Neuberger Berman Group
INSM icon

Neuberger Berman Group’s Insmed INSM Stock Holding History

Neuberger Berman Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4M Buy
378,816
+108,116
+40% +$13.1M 0.03% 558
2026
Q1 		$44.3M Buy
270,700
+62,831
+30% +$9.66M 0.03% 503
2025
Q4 		$36.2M Buy
207,869
+57,763
+38% +$10.5M 0.03% 533
2025
Q3 		$21.6M Buy
150,106
+139,211
+1,278% +$17.1M 0.02% 653
2025
Q2 		$1.1M Sell
10,895
-165,738
-94% -$12.7M ﹤0.01% 1325
2025
Q1 		$13.5M Buy
176,633
+27,392
+18% +$2.1M 0.01% 709
2024
Q4 		$10.3M Buy
149,241
+37,403
+33% +$2.69M 0.01% 802
2024
Q3 		$8.16M Sell
111,838
-1,910
-2% -$141K 0.01% 835
2024
Q2 		$7.62M Sell
113,748
-57,169
-33% -$2.22M 0.01% 819
2024
Q1 		$4.64M Sell
170,917
-166,939
-49% -$4.67M ﹤0.01% 946
2023
Q4 		$10.5M Buy
337,856
+228,352
+209% +$5.92M ﹤0.01% 901
2023
Q3 		$2.76M Sell
109,504
-146,706
-57% -$3.36M ﹤0.01% 1017
2023
Q2 		$5.41M Buy
256,210
+107,402
+72% +$2.04M ﹤0.01% 871
2023
Q1 		$2.54M Buy
148,808
+11,245
+8% +$218K ﹤0.01% 1030
2022
Q4 		$2.75M Buy
137,563
+50,204
+57% +$970K ﹤0.01% 998
2022
Q3 		$1.88M Sell
87,359
-288
-0.3% -$6.91K ﹤0.01% 1097
2022
Q2 		$1.73M Buy
87,647
+36,347
+71% +$762K ﹤0.01% 1149
2022
Q1 		$1.21M Buy
51,300
+5,113
+11% +$119K ﹤0.01% 1300
2021
Q4 		$1.25M Buy
46,187
+30
+0.1% +$858 ﹤0.01% 1297
2021
Q3 		$1.26M Sell
46,157
-75,000
-62% -$1.97M ﹤0.01% 1261
2021
Q2 		$3.44M Buy
+121,157
New +$3.6M ﹤0.01% 1053
2015
Q3 		– Sell
-34,400
Closed -$840K – 1559
2015
Q2 		$840K Buy
34,400
+8,400
+32% +$191K ﹤0.01% 1237
2015
Q1 		$541K Buy
+26,000
New +$458K ﹤0.01% 1330
2013
Q4 		– Sell
-86,900
Closed -$1.36M – 1638
2013
Q3 		$1.36M Buy
+86,900
New +$1.1M ﹤0.01% 1140

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Neuberger Berman Group's INSM Position: Q2 2026 in Review

Neuberger Berman Group increased its Insmed (INSM) stake by 40% in Q2 2026, buying an estimated $13.1M and bringing the position to 378,816 shares worth $40.4M. The position accounts for 0.03% of the portfolio, ranked #558.

Neuberger Berman Group first reported a position in INSM in Q3 2013 and has held it in 24 quarters since. The position peaked at $44.3M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Neuberger Berman Group held 378,816 shares of Insmed worth $40.4M as of Q2 2026.
  • Neuberger Berman Group bought 108,116 Insmed shares in Q2 2026, an estimated $13.1M.
  • Insmed made up 0.03% of Neuberger Berman Group's portfolio in Q2 2026, its #558 holding.
  • Neuberger Berman Group first reported a position in Insmed in Q3 2013 and has held it in 24 quarters since.
  • Neuberger Berman Group's Insmed position peaked at $44.3M in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.